| Literature DB >> 33526784 |
Evan Amalfitano1, Margot Karlikow1, Masoud Norouzi1, Katariina Jaenes1, Seray Cicek1, Fahim Masum1, Peivand Sadat Mousavi1, Yuxiu Guo1, Laura Tang1, Andrew Sydor2, Duo Ma3, Joel D Pearson4,5,6, Daniel Trcka4, Mathieu Pinette7, Aruna Ambagala7, Shawn Babiuk7, Bradley Pickering7,8,9, Jeff Wrana4,10, Rod Bremner4,5,6, Tony Mazzulli6,11, David Sinton12, John H Brumell2,10,13,14, Alexander A Green3,15, Keith Pardee16,17.
Abstract
Recent advances in cell-free synthetic biology have given rise to gene circuit-based sensors with the potential to provide decentralized and low-cost molecular diagnostics. However, it remains a challenge to deliver this sensing capacity into the hands of users in a practical manner. Here, we leverage the glucose meter, one of the most widely available point-of-care sensing devices, to serve as a universal reader for these decentralized diagnostics. We describe a molecular translator that can convert the activation of conventional gene circuit-based sensors into a glucose output that can be read by off-the-shelf glucose meters. We show the development of new glucogenic reporter systems, multiplexed reporter outputs and detection of nucleic acid targets down to the low attomolar range. Using this glucose-meter interface, we demonstrate the detection of a small-molecule analyte; sample-to-result diagnostics for typhoid, paratyphoid A/B; and show the potential for pandemic response with nucleic acid sensors for SARS-CoV-2.Entities:
Year: 2021 PMID: 33526784 DOI: 10.1038/s41467-020-20639-6
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919